Home - Products - Others - Other Targets - GLP-1 moiety from Dulaglutide

GLP-1 moiety from Dulaglutide

CAS No. ——

GLP-1 moiety from Dulaglutide( —— )

Catalog No. M30015 CAS No. ——

GLP-1 moiety from Dulaglutide is a 31-amino acid fragment of Dulaglutide which is a glucagon-like peptide 1 receptor (GLP-1) agonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote

Biological Information

  • Product Name
    GLP-1 moiety from Dulaglutide
  • Note
    Research use only, not for human use.
  • Brief Description
    GLP-1 moiety from Dulaglutide is a 31-amino acid fragment of Dulaglutide which is a glucagon-like peptide 1 receptor (GLP-1) agonist.
  • Description
    GLP-1 moiety from Dulaglutide is a 31-amino acid fragment of Dulaglutide which is a glucagon-like peptide 1 receptor (GLP-1) agonist.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    ——
  • Formula Weight
    3314.62
  • Molecular Formula
    C149H221N37O49
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    Sequence:His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Glu-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Gly-Gly

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

Anthony Celeste, et al. Anti-pcsk9-glp-1 fusions and methods for use. US 20160369010 A1.
molnova catalog
related products
  • NIC3

    NIC3 is a selective nucleus accumbens-associated protein-1 (NAC1) inhibitor, with anti-cancer activity.

  • TT-012

    TT-012 has anti-tumor activity, selectively binds dynamic MITF and disrupts the dimer formation and DNA binding of the latter.

  • J-14

    J-14 is an inhibitor of reversible sulfiredoxin(IC50 : 8.1 μM).?J14 induces oxidative stress (intracellular ROS accumulation) by inhibiting sulfiredoxin leading to cytotoxicity and cancer cell death.